Literature DB >> 1386313

Immunobiological studies on experimental visceral leishmaniasis. II. Adherent cell-mediated down-regulation of delayed-type hypersensitivity response and up-regulation of B cell activation.

S K Basak1, B Saha, A Bhattacharya, S Roy.   

Abstract

Visceral leishmaniasis or kala-azar is characterized by a variety of immunopathological consequences in man. The most remarkable of these are the depression of cell-mediated immunity and polyclonal B cell activation. The consequences observed in man could be induced in a murine model by inoculating the causative agent, Leishmania donovani. The cell-mediated response was studied in this murine model in terms of the delayed-type hypersensitivity (DTH) response toward leishmania antigen in a progressive infection. BALB/b (H-2b) mice showed progressive enhancement in the DTH response, whereas BALB/c (H-2d) mice showed strong DTH at the onset which gradually disappeared (defined as DTH-negative phase) and reappeared again at the later stage of infection. Adoptive transfer of enriched populations of splenic T cells from infected BALB/c mice together with parasite antigen into the footpad of syngenic normal recipients produced a dramatic enhancement in the DTH response, except at the onset of the DTH-negative phase. These observations indicate that adherent cells have a role in suppression of the cell-mediated immune response and also that another mechanism operates at the onset of the DTH-negative phase. This DTH-negative phase was not caused by depletion of DTH-mediating cells from the repertoire, but rather by suppression mediated by a subset of T cell evolved in the course of infection. Characterization on the basis of lymphokine production of the T cells mediating the DTH response and of T cells mediating suppression of the DTH response showed them to be of Th1 and Th2 type, respectively. Studies also indicated that at the onset and the later stages of infection suppression was mediated by adherent cells, but at the onset of DTH-negative phase, in particular, suppression was mediated by Th2 cells. Furthermore, experiments also showed that adherent cells from infected mice gained another property, that of driving B cells, in a T cell-dependent manner.

Entities:  

Mesh:

Year:  1992        PMID: 1386313     DOI: 10.1002/eji.1830220813

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

1.  Use of an attenuated leishmanial parasite as an immunoprophylactic and immunotherapeutic agent against murine visceral leishmaniasis.

Authors:  S Mukhopadhyay; S Bhattacharyya; R Majhi; T De; K Naskar; S Majumdar; S Roy
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

Review 2.  Redundant and regulatory roles for Toll-like receptors in Leishmania infection.

Authors:  P Chauhan; D Shukla; D Chattopadhyay; B Saha
Journal:  Clin Exp Immunol       Date:  2017-08-07       Impact factor: 4.330

3.  Adjuvanticity and protective immunity elicited by Leishmania donovani antigens encapsulated in positively charged liposomes.

Authors:  F Afrin; N Ali
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

4.  Distribution of IgG subclasses in antimonial unresponsive Indian kala-azar patients.

Authors:  M Chatterjee; K Basu; D Basu; D Bannerjee; N Pramanik; S K Guha; R P Goswami; S K Saha; C Mandal
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

5.  Hybrid cell vaccination resolves Leishmania donovani infection by eliciting a strong CD8+ cytotoxic T-lymphocyte response with concomitant suppression of interleukin-10 (IL-10) but not IL-4 or IL-13.

Authors:  Rajatava Basu; Suniti Bhaumik; Arun Kumar Haldar; Kshudiram Naskar; Tripti De; Syamal Kumar Dana; Peter Walden; Syamal Roy
Journal:  Infect Immun       Date:  2007-10-01       Impact factor: 3.441

6.  Th1-biased immunomodulation and therapeutic potential of Artemisia annua in murine visceral leishmaniasis.

Authors:  Mohammad Islamuddin; Garima Chouhan; Abdullah Farooque; Bilikere S Dwarakanath; Dinkar Sahal; Farhat Afrin
Journal:  PLoS Negl Trop Dis       Date:  2015-01-08

7.  Alcoholic Fractions F5 and F6 from Withania somnifera Leaves Show a Potent Antileishmanial and Immunomodulatory Activities to Control Experimental Visceral Leishmaniasis.

Authors:  Sambamurthy Chandrasekaran; Jalaja Veronica; Shyam Sundar; Radheshyam Maurya
Journal:  Front Med (Lausanne)       Date:  2017-05-12

Review 8.  Host-cell lipid rafts: a safe door for micro-organisms?

Authors:  Flávia Sarmento Vieira; Gladys Corrêa; Marcelo Einicker-Lamas; Robson Coutinho-Silva
Journal:  Biol Cell       Date:  2010-04-06       Impact factor: 4.458

9.  Cholesterol Corrects Altered Conformation of MHC-II Protein in Leishmania donovani Infected Macrophages: Implication in Therapy.

Authors:  Koushik Roy; Sapan Mandloi; Saikat Chakrabarti; Syamal Roy
Journal:  PLoS Negl Trop Dis       Date:  2016-05-23

10.  Leptin regulates Granzyme-A, PD-1 and CTLA-4 expression in T cell to control visceral leishmaniasis in BALB/c Mice.

Authors:  Alti Dayakar; Sambamurthy Chandrasekaran; Jalaja Veronica; Vadloori Bharadwaja; Radheshyam Maurya
Journal:  Sci Rep       Date:  2017-11-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.